BIT
RCPI

BlackRock Institutional Trust’s ROCK CREEK PHARMACEUTICALS INC COM STK (DE) RCPI Stock Holding History

BlackRock Institutional Trust’s Portfolio RCPI Stock Details RCPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-198,937
Closed -$163K – 4066
2015
Q3 		$163K Hold
198,937
– – ﹤0.01% 3669
2015
Q2 		$302K Buy
198,937
+37,564
+23% +$89.5K ﹤0.01% 3581
2015
Q1 		$412K Buy
161,373
+16,959
+12% +$66.8K ﹤0.01% 3539
2014
Q4 		$657K Buy
144,414
+2,466
+2% +$13K ﹤0.01% 3448
2014
Q3 		$994K Buy
141,948
+22,365
+19% +$221K ﹤0.01% 3328
2014
Q2 		$1.76M Buy
+119,583
New +$2.08M ﹤0.01% 3246

Other funds holding RCPI

Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
KCM
Kempner Capital Management Galveston, Texas $106M AUM 29.1% 1-Year Est. Return
WP
WealthPLAN Partners Omaha, Nebraska $523M AUM 23.92% 1-Year Est. Return
IWMPD
Integrated Wealth Management (Palm Desert) Palm Desert, California $299M AUM 12.85% 1-Year Est. Return

BlackRock Institutional Trust's RCPI Position: Q4 2015 in Review

BlackRock Institutional Trust sold out of ROCK CREEK PHARMACEUTICALS INC COM STK (DE) (RCPI) in Q4 2015, closing a stake of 198,937 shares — an estimated $163K sold.

BlackRock Institutional Trust first reported a position in RCPI in Q2 2014 and held it in 6 quarters. The position peaked at $1.76M in Q2 2014. 9 funds tracked by Wall St. Rank hold RCPI as of Q4 2015.

  • BlackRock Institutional Trust reported no remaining ROCK CREEK PHARMACEUTICALS INC COM STK (DE) position as of Q4 2015 after selling out during the quarter.
  • BlackRock Institutional Trust sold 198,937 ROCK CREEK PHARMACEUTICALS INC COM STK (DE) shares in Q4 2015, an estimated $163K.
  • BlackRock Institutional Trust first reported a position in ROCK CREEK PHARMACEUTICALS INC COM STK (DE) in Q2 2014 and held it in 6 quarters.
  • BlackRock Institutional Trust's ROCK CREEK PHARMACEUTICALS INC COM STK (DE) position peaked at $1.76M in Q2 2014.
  • 9 funds tracked by Wall St. Rank held ROCK CREEK PHARMACEUTICALS INC COM STK (DE) as of Q4 2015.

Based on BlackRock Institutional Trust's 13F filing for Q4 2015, filed 11 Feb 2016.